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In order to determine the occurrence and frequency of resistant strains of the bacterium Campylobacter jejuni
and to establish baseline MICs in isolates from an environmental reservoir, the resistance profiles of 10
antimicrobial substances were determined for 137 C. jejuni isolates from wild birds in Sweden. Observed MICs
were generally low, with only low to moderate incidence of resistance to the tested compounds. One isolate,
however, was resistant to nalidixic acid and ciprofloxacin, indicating that quinolone-resistant genotypes of
C. jejuni have the potential to spread to wild bird hosts.
Currently, there is an intense debate on the use and misuse
of antimicrobial agents in the raising of livestock for food and
their sometimes imprudent prescription for therapeutic use in
humans (2, 12). From the farm perspective, animal health and
farm economics is balanced against the associated risk of bac-
terial pathogens acquiring antimicrobial resistance (7, 19). As
laws and control measures differ between countries, there are
often large variations between nations in their total and per
capita use of antimicrobial agents in both human and veteri-
nary medicine, with a general trend towards more unrestricted
use in developing countries.
The enteropathogens Campylobacter jejuni and Salmonella
spp. represent an important public health problem. Domestic
animals constitute a significant reservoir for these zoonotic
agents that are typically food borne (17, 21). Resistance ac-
quired by these bacteria in response to antimicrobial selection
pressures in livestock production could severely hamper the
treatment of human infections, especially when the same class
of antimicrobial agents is used in the two systems (2, 26). In a
worst-case scenario, with multiresistant bacteria, there would
be few, if any, antimicrobial compounds available for clinical use.
One important question specifically addressed in the present
study is whether resistant bacteria are directly or indirectly
“leaking” out from humanmade systems into the environment.
The study focuses on C. jejuni, one of the leading causes of
acute bacterial gastroenteritis in humans (11), and analyzes the
antimicrobial resistance profiles of C. jejuni isolates obtained
from a large collection of wild birds. Important risk factors for
acquiring C. jejuni infection include consumption of under-
cooked poultry meat, cross-contamination from poultry meat
to other food products, and drinking inadequately pasteurized
milk or untreated drinking water (3, 11, 23). There are, how-
ever, good reasons to believe that less well-known sources may
be important in the epidemiology of the bacterium, as many
outbreaks and sporadic cases are left unresolved (16, 20). Apart
from the well-known poultry reservoir, C. jejuni occurs natu-
rally in both domesticated and wild mammals and birds (27),
and it has been isolated from surface and groundwater (16).
Taken together, these elements set the stage for potential trans-
fer of resistant strains in and out of food production systems.
In the present study, we determined the susceptibility of 137
C. jejuni strains isolated from free-flying healthy birds. The
tested strains were chosen to represent three different groups
of bird hosts: thrushes, shorebirds, and raptors, all previously
known to harbor significant levels of C. jejuni (5, 27).
MATERIALS AND METHODS
Origin of strains. The C. jejuni strains investigated in this study came from
ongoing studies of the occurrence and distribution of Campylobacter spp. in
different free-flying bird species in Sweden. In this project, birds were trapped
and sampled at Ottenby Bird Observatory (56° 12N, 16° 24E) when they
stopped over in the area during their northbound spring or southbound autumn
migration. For details on trapping, sampling, and primary isolation procedures,
see previously published descriptions (6, 27). One-hundred thirty-nine strains,
presumptively identified as C. jejuni based on morphology and limited pheno-
typic testing (catalase, oxidase, and hippurate hydrolysis), were chosen from a
larger collection of strains in order to achieve representatives from three differ-
ent groups of wild birds: thrushes (family Muscicapidae, genus Turdus), raptors
(families Strigidae and Accipitridae, genera Asio and Accipiter), and shorebirds
(family Scolopacidae, genera Calidris, Limicola, Tringa) (Table 1). The presump-
tive bacterial species identity was later validated using molecular methods. All
isolates were first tested in a multiplex PCR method that gives separate species-
specific amplifications of C. jejuni and C. coli genes (25). PCR conditions and
reactions were performed as described in the original study (25). Template DNA
for the PCRs consisted either of purified chromosomal DNA (92 isolates; Pure-
gene DNA Isolation Kit; Gentra Systems, Minneapolis) or extracted DNA from
48-h-old subcultures grown on heart infusion (HI) agar (Difco; product no.
244400), supplemented with 5% sheep blood, using a 20% Chelex-100 slurry
(Bio-Rad; product no. 142-2842), as described previously (9). Clear positive
amplicons specific for C. jejuni were observed for all but four tested isolates. The
remaining isolates were subjected to a previously described combined PCR and
restriction fragment analysis method (10), where three isolates gave C. jejuni–
pecific restriction patterns and the last C. coli-specific pattern (this isolate was
excluded from the study).
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Susceptibility tests. Susceptibility was tested quantitatively with an adjusted
broth microdilution test according to NCCLS guideline M31-A2. For broth
microdilution, microtiter trays were used with dehydrated dilution ranges of
custom-made panels of antimicrobial agents (Trek Diagnostic Systems, United
Kingdom). The agents included in the panels are presented in Table 2. After
inoculation of the microtiter trays with 50 l of a 200-fold-diluted 0.5 McFarland
suspension in Mueller Hinton-II broth (MH-II broth; Lab M; product no. Lab
39, supplemented with 0.2 IU/ml thymidine phosphorylase; Sigma; product no.
T7006) of a 48-h-old pure culture on blood agar, the trays were incubated
microaerobically in a shaking incubator at 37°C for 24 h (80 to 100 rpm). C. jejuni
ATCC 33560 was used as the control strain. All isolates from thrushes and one
from an owl failed to grow sufficiently in MH-II broth, and for these strains heart
infusion (HI) broth (Difco; product no. 238400) was used instead. The MICs
were defined as the lowest concentrations in the wells where no visual growth
could be observed.
RESULTS
Of the 139 bird isolates, 94 failed to grow sufficiently in
MH-II broth. For these isolates HI broth was used in the
microdilution tests. One isolate failed to grow also in the HI
broth and, consequentially, its resistance profile could not be
determined. Another isolate was identified as C. coli and was
omitted from further analyses. The MICs for the control strain
C. jejuni ATCC 33560 to ciprofloxacin, nalidixic acid, and
erythromycin were always within tentative quality control (QC)
ranges for the agar dilution method (NCCLS document M31-
A2), irrespective of the broth used. The MIC of the control
strain to doxycycline was only once one dilution step below the
QC ranges, and the MIC to gentamicin was four out of six
times one dilution step below the QC ranges. For the other
antimicrobial agents, QC ranges did not exist yet, so the results
were interpreted with more care. For C. jejuni ATCC 33560
the MIC to amoxicillin varied between 4 and 8 g/ml, to chlor-
amphenicol the MIC varied between 2 and 8 g/ml, to met-
ronidazole the MIC varied between 0,5 and 1 g/ml, to neo-
mycin the MIC varied between 0,5 and 2 g/ml, and to
streptomycin the MIC varied between 1 and 2 g/ml, irre-
spective of the broth used.
All isolates were found to be susceptible to chloramphenicol,
erythromycin, gentamicin, neomycin, and streptomycin (Table
2). Low resistance prevalences (0.7 to 3.6%) were observed for
four compounds: amoxicillin, ciprofloxacin, doxycycline, and na-
lidixic acid, whereas a moderate resistance prevalence (14.6%)
was found to metronidazole (Table 2).
When all substances were considered, two of the bird spe-
cies, long-eared owl and blackbird, more often carried resistant
C. jejuni isolates than other species (Table 3). This was partic-
ularly evident for metronidazole. Notably, the eight isolates
from long-eared owls showed resistance to four of the tested
compounds, and one of these was simultaneously resistant to
nalidixic acid and ciprofloxacin.
DISCUSSION
The use of antimicrobial agents in the rearing of poultry and
other food-producing animals is perceived by many as a strong
threat to public health, as bacteria in these systems, including
pathogenic ones, are under strong selection for acquiring re-
sistance to antimicrobial compounds. The threat can be di-
vided into two parts: first, resistant zoonotic bacteria that sur-
vive all production steps could end up in the food consumed by
humans; second, selection for anti-antimicrobial genes could
spread these alleles within clonal complexes of bacteria or be
transferred horizontally to other bacterial species. In the latter
case, resistance genes selected for in a harmless commensal
bacterium could jump to a pathogenic species, where human or
animal health considerations are much greater. Resistant ge-
notypes could spread from farms into the environment by a
number of ways, but the important question to ask is whether
these genotypes can persist in, and further spread to, any
environmental reservoirs such as wild birds. If so, a feed-back
loop from one farm through the environmental reservoir to the
next could be possible.
Overall, the incidence of resistance to antimicrobial agents
was low for the investigated wild bird isolates. There are a
number of published studies in the human and veterinary lit-
erature on the degree of acquired resistance to antimicrobial
compounds; many that report considerably higher incidences
of resistance than those seen in this study (1). For instance,
data obtained in the same lab as in this study on the occurrence
of resistant isolates of C. jejuni in Dutch humans (1998 to 1999)
and Dutch poultry (2000 to 2003) reported that 7.8% and
24.3% of investigated strains were resistant to amoxicillin,
23.4% and 36.3% to ciprofloxacin, and 16.9% and 27.1% to
doxycycline, respectively (15). The wild birds in this study were
sampled during their annual migrations between breeding and
wintering areas and vice versa. Thus, the C. jejuni strains may
have colonized the birds in areas far from the sampling site.
However, values from Swedish broiler chickens (4) were rather
similar to those observed in the wild bird isolates, with 7.1% of
isolates resistant to ampicillin, 0.8% to enrofloxacine, and
0.8% to tetracycline (2001 to 2002; n  127).
The highest resistance prevalences were seen in isolates
TABLE 1. Number of Campylobacter jejuni isolates from
different host species placed into ecological groups
Group Host species n
Thrushes Blackbird 41
Turdus merula
Song thrush 39
Turdus philomelos
Redwing 11
Turdus iliacus
Fieldfare 2
Turdus pilaris
Mistle thrush 1
Turdus viscivorus
Raptors Long-eared owl 8
Asio otus
Sparrowhawk 1
Accipiter nisus
Shorebirds Dunlin 31
Calidris alpina
Broad-billed sandpiper 1
Limicola falcinellus
Curlew sandpiper 1
Calidris ferruginea
Little stint 2
Calidris minuta
Wood sandpiper 1
Tringa glareola
Total 139
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from the raptor group, which consisted mainly of long-eared
owls. From one of these owls, an isolate with resistance to both
nalidixic acid and ciprofloxacin was retrieved. The resistance to
fluoroquinolones is caused by a point mutation in the gyrA
gene (18) and has been shown to occur rapidly both in vitro
and in vivo in the presence of this class of antimicrobial com-
pounds (13, 18, 24). The few studies that have examined ge-
netic similarities of C. jejuni strains isolated from wild birds to
those of chickens and humans have shown that wild bird strains
generally are different from isolates from other sources, but
that similar genetic fingerprints sometimes occur (5, 6). The
finding of a quinolone-resistant C. jejuni isolate could thus
represent a resistant phenotype that has originated within an-
other reservoir. Long-eared owls are essentially nocturnal and
TABLE 2. MIC values to different antimicrobial compounds in 137 Campylobacter jejuni isolates from
wild shorebirds (A), thrushes (B), and raptors (C)a
Drug Bird
Amt of drug (g/ml)
n
Breakpoint for
resistance
(g/ml)
Resistance
0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1,024
Amoxicillin All 1 2 2 23 31 45 28 5 137 16 3.6
A 1 8 26 35 0.0
B 1 2 2 22 28 33 2 3 93 3.2
C 1 2 4 2 9 22.2
Chloramphenicol All 101 33 3 137 16 0.0
A 24 11 35 0.0
B 68 22 3 93 0.0
C 9 9 0.0
Ciprofloxacin All 58 48 21 9 1 137 2 0.7
A 12 22 1 35 0.0
B 38 26 20 9 93 0.0
C 8 1 9 11.1
Doxycycline All 101 25 7 2 1 1 137 4 0.7
A 34 1 35 2.9
B 59 25 7 2 93 0.0
C 8 1 9 0.0
Erythromycin All 15 49 56 10 7 137 16 0.0
A 12 15 6 2 35 0.0
B 1 28 49 8 7 93 0.0
C 2 6 1 9 0.0
Gentamicin All 70 67 137 8 0.0
A 35 35 0.0
B 26 67 93 0.0
C 9 9 0.0
Metronidazole All 15 55 38 9 5 8 5 1 1 137 4 14.6
A 1 24 8 1 1 35 5.7
B 12 28 30 9 3 7 3 1 93 15.1
C 2 3 2 1 1 9 44.4
Nalidixic acid All 1 2 45 47 38 3 1 137 32 0.7
A 8 22 5 35 0.0
B 32 25 33 3 93 0.0
C 1 2 5 1 9 11.1
Neomycin All 63 66 7 1 137 8 0.0
A 34 1 35 0.0
B 21 64 7 1 93 0.0
C 8 1 9 0.0
Streptomycin All 132 5 137 8 0.0
A 34 1 35 0.0
B 89 4 93 0.0
C 9 9 0.0
a MICs are in micrograms per milliliter. Also given are MIC breakpoint values and the corresponding incidence of resistance (in percentages).
TABLE 3. Seasonal distribution of isolates resistant to tested antimicrobial agents (numbers of the isolates are placed in brackets)
Host species Amoxicillin Ciprofloxacin Doxycycline Metronidazole Nalidixic acid
Accipiter nisus Sep (1)
Asio otus Nov (1) Oct (1) Apr (2), Oct (1), Nov (1) Oct (1)
Turdus merula Apr (5), Oct (2), Nov (2)
Turdus philomelos Apr (2) Oct (2)
Turdus viscivorus Mar (1)
Turdus iliacus Apr (1)
Calidris alpina Jul (1) Jul (2)
Tringa glareola
Limicola falcinellus
Total 5 1 1 20 1
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feed mainly on small rodents (especially voles Microtinae, and
mice Murinae), but they also include passerine birds in their
diet (ca. 2 to 17% of identified remains from pellets [8]).
Elevated MIC values were also observed among wild bird
isolates for amoxicillin, doxycycline, and metronidazole. For
amoxicillin, however, all the five isolates in question produced
MIC values that were only one dilution step above the break-
point of 16 g/ml (Table 2). The varying MICs of 4 to 8 g/ml
for the internal standard, C. jejuni ATCC 33560, to this com-
pound indicate that the methodology may have been subopti-
mal. An allowance for a methodology error of one dilution step
would place all isolates scored here as resistant below the
breakpoint. The single isolate that showed resistance to doxy-
cycline (Table 2), obtained from a Dunlin (Calidris alpina),
grew in 4-dilution-steps higher concentration than did the iso-
lates with the second highest MIC. Therefore, the elevated
MIC in this isolate is more likely to reflect a true resistance. A
total of 14.5% of all isolates had MIC values for metronidazole
that exceeded the breakpoint. There was also a tendency to a
bimodal MIC value distribution for this substance. Metronida-
zole-resistant isolates were found in all three bird groups but
were more frequent among raptors and thrushes (Table 2).
The mechanisms behind the resistance to metronidazole in
Campylobacter spp. are not yet fully understood. Reduction of
the 5-nitro group of the imidazole ring to nitro-radical anions
responsible for the species-specific effects on DNA have been
described in anaerobes and is probably also responsible for the
activity in Campylobacter species. In the related bacterium Hel-
icobacter pylori, resistance to metronidazole can result from the
loss of activity of an oxygen-independent NADPH nitroreduc-
tase due to mutations in the rdxA gene. However, the existence
of this pathway in Campylobacter spp. has not been validated
(14). The observation that metronidazole resistance in C. jejuni
is associated with strains isolated from birds was described
previously by Stanley and Jones (22) and is confirmed by the
results of the present study. Selection for metronidazole resis-
tance by the use of dimetridazole derivatives in birds was
considered highly unlikely, and a host phenotype relationship
was suggested (22).
The present study provides valuable baseline data on MIC
values in C. jejuni isolates from three groups of wild birds
sampled in Sweden. Most of the host species studied here are
not normally found close to human settlements, and the results
could have been different if we had studied bird species that
were more associated with human activities. Nevertheless, we
found one bacterial isolate with resistance to quinolones, in-
dicating that resistant genotypes can leak out into the wild bird
reservoir.
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